KEGG   DRUG: D09214Help
Entry
D09214                      Drug                                   

Name
Ustekinumab (genetical recombination) (JAN);
Ustekinumab (USAN/INN);
Stelara (TN)
Product
Formula
C6482H10004N1712O2016S46
Exact mass
145556.0074
Mol weight
145646.04
Activity
Treatment of immunologically mediated inflammatory disorders
Remark
Therapeutic category: 
ATC code: 
Comment
Monoclonal antibody
Target
interleukin 12 [HSA:3592 3593] [KO:K05406 K05425];
interleukin 23 [HSA:51561] [KO:K05426]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  Jak-STAT signaling pathway  
 
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AC Interleukin inhibitors
     L04AC05 Ustekinumab
      D09214  Ustekinumab (genetical recombination) (JAN); Ustekinumab (USAN/INN)
USP drug classification [BR:br08302]
 Dermatological Agents
  Ustekinumab
   D09214  Ustekinumab (genetical recombination) (JAN); Ustekinumab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D09214  Ustekinumab (genetical recombination) (JAN); Ustekinumab (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Cytokines
  Class I cytokines
   IL-12
    Ustekinumab
     D09214  Ustekinumab (genetical recombination) (JAN); Ustekinumab (USAN/INN)
   IL-23
    Ustekinumab
     D09214  Ustekinumab (genetical recombination) (JAN); Ustekinumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
815610-63-0
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system